Hwaseong-si, South Korea

Myung-Hun Cha



 

Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Anyang-si, KR (2010)
  • Anyang, KR (2010 - 2012)
  • Gyeonggi-do, KR (2017 - 2018)
  • Hwaseong-si, KR (2019 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Myung-Hun Cha: Innovator in Pharmaceutical Development

Introduction

Myung-Hun Cha is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work focuses on developing innovative solutions for gastrointestinal diseases, showcasing his commitment to improving patient care.

Latest Patents

One of Myung-Hun Cha's latest patents involves diaminopyrimidine derivatives and processes for their preparation. This invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, along with a process for its preparation. The pharmaceutical composition derived from this invention functions as a 5-HT receptor agonist. It can be effectively applied to prevent or treat dysfunction in gastrointestinal motility, addressing various gastrointestinal diseases such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, and diabetic gastric atony.

Career Highlights

Myung-Hun Cha is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His role at Yuhan Corporation allows him to leverage his expertise in pharmaceutical innovation and contribute to the development of new therapeutic solutions.

Collaborations

Throughout his career, Myung-Hun Cha has collaborated with notable colleagues, including Young-Ae Yoon and Dong-Hoon Kim. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Myung-Hun Cha's contributions to pharmaceutical development, particularly in gastrointestinal treatments, highlight his role as a key innovator in the industry. His patents reflect a dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…